Dacarbazine Citrate

6 trials 5 recruiting LOncology

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

5 Recruiting

1 Completed trials

6 Sponsors

14 Countries

Phase III

Phase II

Phase III: 3 Phase II: 3

Indications tested

Hodgkin's disease 1 Uveal melanoma 1 Ocular melanoma 1

Sponsors using this IMP

Erasca Inc. 1 European Organisation For Research And Treatment Of Cancer 1 iOnctura SA 1 Oncopole Claudius Regaud 1 Replimune Group Inc. 1 University Of Cologne 1

All trials

6 total

A RANDOMIZED, OPEN-LABEL PHASE 3 STUDY IN PATIENTS WITH PREVIOUSLY TREATED UNRESECTABLE OR METASTATIC NRAS MUTANT CUTANEOUS MELANOMA COMPARI… Recruiting

2024-511404-17-00 Phase III 10 countries Erasca Inc.
Pembro-FLASH Recruiting

2022-501458-13-01 Phase II 1 country University Of Cologne
A Study to Compare Vusolimogene oderparepvec (VO) Plus Nivolumab With the Doctor's Choice of Treatment in People With Skin Cancer That has G… Recruiting

2023-508612-29-00 Phase III 6 countries Replimune Inc.
Phase II study of Roginolisib in UM patients Recruiting

2024-514333-37-00 Phase II 2 countries iOnctura SA
Interest of peri operative CHemotherapy In patients with CINSARC highrisk localized Soft Tissue Sarcoma. Recruiting

2024-515384-62-00 Phase III 1 country Oncopole Claudius Regaud
EORTC-1537-LYMG: Very early FDG-PET-response adapted targeted therapy for advanced Hodgkin lymphoma: a single-arm phase II study Ended

2023-508478-27-00 Phase II 7 countries European Organisation For Research And Treatment Of Cancer

Showing 1–6 of 6 trials

← All drugs A–Z